Traders expect volatility after Indian shares rise to near three-year highs as the central bank is expected to raise interest rates by 25 bps at its policy review on Oct. 29, its second monthly consecutive hike.
Global markets will also be in focus as the U.S. Federal Reserve holds its policy meeting on Oct. 29-30.
The expiry of October derivative contracts on Oct. 31 could further add to the volatility, traders say.
Markets will also be focused on earnings from drug exporters including Lupin Ltd and Dr.Reddy's Laboratories Ltd.
Overseas flows will also be key after foreign institutional investors (FIIs) bought a total of nearly 125 billion Indian rupees ($2.04 billion) over 15 sessions until Thursday, according to regulatory and exchange data.
KEY FACTORS/EVENTS TO WATCH
Sat: Hindustan Unilever Ltd earnings
Mon: Earnings of Maruti Suzuki India Ltd
Tues: RBI's monetary policy review, results of Ranbaxy Laboratories Ltd
Thurs: IDFC Ltd, Dr.Reddy's Laboratories Ltd